President's Corner

BayBio Will Work for Your Success

I am very pleased to provide you with BayBio’s Annual Report on our organizations’ activities. Thank you for your support over the last several years, it allows us to improve the services we provide to Northern California’s life sciences community. For the first time, we have posted our annual report online. View it here.

Our industry faces challenging times. Early-stage researchers are increasingly stunted in their efforts to access public capital, and regulatory uncertainty at the FDA and here at home in California has stifled private investment. Now more than ever, our members need to stretch every dollar. BayBio is fortifying its efforts to help your organization maximize increasingly limited resources.

To help members access private funding, BayBio launched Pharma Partnering Days in 2011 to bring small innovative companies together with large biopharmaceuticals to discuss collaboration and investment opportunities. We also launched the BayBio Fellows Program and Expert Network, which are helping more than 70 entrepreneurs navigate the startup waters.

We also seek to impact your bottom line by looking for ways to save our members precious dollars. Through a trust formed by BayBio, BIOCOM, and Barney and Barney, we began offering bioscience members the group healthcare program Beyond Benefits.

After our successful BayBio2011 Annual Conference, we expanded to a statewide event in 2012. CALBIO2012 brings Northern and Southern California life sciences companies together with global pharmas, disease foundations and patient groups to facilitate collaboration and the sharing of best practices.

BayBio’s policy efforts will continue to build on strategic coalitions with AdvaMed, BIO, BIOCOM, CHI, MDMA, NVCA, PhRMA, and others to bring a united voice to our policy agenda in Sacramento and Washington, D.C.

As we endeavor to enact pro-innovation policies at the state and federal level, your participation is critical. When you encounter challenges with duplicative regulations, accessing capital, or delayed FDA approval for your products – we need to know. This will allow us to develop a repository of our collective real-world obstacles and to better speak with a unified voice that will benefit our industry and our patients.

BayBio’s activities are not possible without the participation and support of our Partners, members, donors and volunteers. Thank you for helping us at BayBio do all we can to serve our industry better.